Table 1.
Formulation parameters and designed particle composition by mass of the human inhalable vaccine candidates.
Component\Formulation | T | T20Leu | T10Pul | T20Pul | T3Tri | T6Tri |
---|---|---|---|---|---|---|
Feedstock Composition (mg/mL) | ||||||
Leucine | - | 10.0 | - | - | - | - |
Pullulan | - | - | 4.5 | 10.5 | - | - |
Trileucine | - | - | - | - | 1.3 | 2.6 |
Trehalose | 33.3 | 33.3 | 33.3 | 33.3 | 33.3 | 33.3 |
Tris (buffer) | 0.807 | 0.807 | 0.807 | 0.807 | 0.807 | 0.807 |
Squalene | 5.73 | 5.73 | 5.73 | 5.73 | 5.73 | 5.73 |
DMPC | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 |
GLA | 0.0033 | 0.0033 | 0.0033 | 0.0033 | 0.0033 | 0.0033 |
ID93 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 |
Total Feed Concentration | 41.1 | 51.1 | 45.6 | 51.6 | 42.4 | 43.7 |
Particle Composition (w/w) | ||||||
Leucine | - | 20% | - | - | - | - |
Pullulan | - | - | 10% | 20% | - | - |
Trileucine | - | - | - | - | 3% | 6% |
Trehalose | 81% | 65% | 73% | 65% | 78% | 76% |
Tris (buffer) | 2% | 2% | 2% | 2% | 2% | 2% |
Squalene | 14% | 11% | 12% | 11% | 14% | 13% |
DMPC | 3% | 2% | 3% | 2% | 3% | 3% |
GLA | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
ID93 | 0.003% | 0.003% | 0.003% | 0.003% | 0.003% | 0.003% |